Our Commitment to Innovation

Innovation stands as the foundation of our commitment to delivering unmatched value to our customers. Since 2016, we’ve steadfastly invested in pioneering research and development, with our annual R&D expenses consistently exceeding 7% of our sales revenue, reaching over 10% in the past two years. We are research-driven and innovation-focused, aiming to revolutionize our field and offer optimal solutions to our customers.

Our Investments in Innovation

• Since 2016: Investment in innovation has been a priority, with a focus on establishing state-of-the-art R&D centers to foster groundbreaking research.
• Annual R&D Expenses: A significant part of our revenue is allocated to R&D, ensuring continuous advancement in our field.

1. Chemical R&D Center (Established in 2016)

• Investment: US$20 million.
• Focus: Building blocks, catalysts, and ligands for the chemical and medicinal chemistry sectors.
• Achievements: Independent synthesis of over 10,000 building block molecules.

2. Biological R&D Center (Established in 2021)

• Investment: US$15 million.
• Focus: Protein and antibody R&D, employing platforms such as the Mammalian Transient Expression and Hybridoma Development.
• Team: Comprises world-renowned experts including immunologists, chemists, and biochemists.

3. Drug Ligand and Target R&D Laboratory (Established in 2022)

• Investment: US$3 million.
• Focus: Research on drug ligands and compound screening, including high-throughput automated systems for synthesizing and expressing more ligands.

Our Impact

• Product Launch: We aim and succeed in introducing more than 20,000 new products annually, tailor-made to meet our customer's needs.
• In-House Development & Manufacturing: Utilizing the latest innovations, we scale our new product development, manufacturing, and commercialization capabilities, offering rapid access to top-notch research tools and materials around the clock.
• Accelerating Life Science Research: Our products, applicable in discovery research, diagnostics, and biopharmaceutical production, are leading the way in accelerating life science research and improving conversion efficiency from R&D to production across various domains.

Innovating through the Internet of Things (IoT) in Digital Ecological Laboratories

The symbiosis between R&D innovation and the interconnectedness of information systems, instruments, and equipment is indispensable. We enhance the efficiency of our R&D scientists by integrating software and essential instruments and equipment through the Internet of Things (IoT). Our investments in IoT technologies within our laboratories, including the Laboratory Information Management System (LIMS), Electronic Laboratory Notebook, Product Lifecycle Management (PLM) R&D system, and Enterprise Resource Planning (ERP) information system, facilitate seamless transmission of Electronic Data Interchange (EDI) data flows between each information module and hardware.

This state-of-the-art laboratory digitization simplifies, accelerates, and secures research and biotechnological production by optimizing operations for scientists and customers and leveraging technology to hasten discoveries. By doing so, we not only propel our scientific endeavors forward but also create an environment where technology and science collaborate to uncover new possibilities.

Discover More About Aladdin:

• Our Facilities
• Core Values
• Sustainability Plan
• Quality Commitment
• Careers
• Meet Our Team
• [Back to About Us]